General Information of the Cell Line
Cell Line ID
CL001027
Cell Line Name
HeLa-P4
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0030
Tissue Information
Uterus
Disease
Human papillomavirus-related cervical adenocarcinoma (NCIt: C27677)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT00903, C-C chemokine receptor type 5
Compound ID Compound Name Compound Formula
CP0423240
N-[(1S)-3-[4-[[2-(3,4-dichlorophenyl)acetyl]-ethylamino]piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C30H39Cl2N3O2
 1
1
IC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0478980
N-[(1S)-3-[4-[ethyl-[2-(4-methylsulfonylphenyl)acetyl]amino]piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C31H43N3O4S
 1
1
IC50 = 0.07 nM
   TI
   LI
   LO
   TS
CP0514717
(+/-)-N-((1S)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutyl)cyclopentanecarboxamide
   Show/Hide
C27H41N5O
 1
1
IC50 = 0.137 nM
   TI
   LI
   LO
   TS
CP0423241
N-[(1S)-3-[4-[benzylcarbamoyl(ethyl)amino]piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C30H42N4O2
 1
1
IC50 = 0.16 nM
   TI
   LI
   LO
   TS
CP0002124
4,4-Difluoro-cyclohexanecarboxylic acid {(S)-3-[(1S,5S)-3-(3-isopropyl-5-methyl-[1,2,4]triazol-4-yl)-8-aza-bicyclo[3.2.1]oct-8-yl]-1-phenyl-propyl}-amide
   Show/Hide
C29H41F2N5O
 1
1
IC50 = 0.2 nM
   TI
   LI
   LO
   TS
CP0478981
N-[(1S)-3-[4-[[2-(4-chlorophenyl)acetyl]-ethylamino]piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C30H40ClN3O2
 1
1
IC50 = 0.34 nM
   TI
   LI
   LO
   TS
CP0468371
(+/-)-3,3-difluoro-N-((1S)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutyl)cyclobutanecarboxamide
   Show/Hide
C26H37F2N5O
 1
1
IC50 = 0.38 nM
   TI
   LI
   LO
   TS
CP0423242
N-[(1S)-3-[4-[ethyl-[2-[4-(trifluoromethyl)phenyl]acetyl]amino]piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C31H40F3N3O2
 1
1
IC50 = 0.48 nM
   TI
   LI
   LO
   TS
CP0493399
3,3-difluoro-N-((1S,3R)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutyl)cyclobutanecarboxamide
   Show/Hide
C26H37F2N5O
 1
1
IC50 = 0.48 nM
   TI
   LI
   LO
   TS
CP0508054
N-benzyl-N-[1-[1-(2,6-dimethylbenzoyl)-4-methylpiperidin-4-yl]piperidin-4-yl]cyclopropanecarboxamide
   Show/Hide
C31H41N3O2
 1
1
IC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0515715
(+/-)-N-((1S)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutyl)cyclohexanecarboxamide
   Show/Hide
C28H43N5O
 1
1
IC50 = 0.513 nM
   TI
   LI
   LO
   TS
CP0541362
(+/-)-4,4-difluoro-N-((1S)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutyl)cyclohexanecarboxamide
   Show/Hide
C28H41F2N5O
 1
1
IC50 = 0.84 nM
   TI
   LI
   LO
   TS
CP0418940
N-[(1S)-3-[4-[ethyl-[2-(4-fluorophenyl)acetyl]amino]piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C30H40FN3O2
 1
1
IC50 = 0.94 nM
   TI
   LI
   LO
   TS
CP0423728
(R)-N-benzyl-N-(1-(1-(2,6-dimethylbenzoyl)piperidin-4-yl)pyrrolidin-3-yl)cyclopropanecarboxamide
   Show/Hide
C29H37N3O2
 1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0509413
N-benzyl-N-[(3R)-1-[(1R,5S)-8-(2,6-dimethylbenzoyl)-8-azabicyclo[3.2.1]octan-3-yl]pyrrolidin-3-yl]cyclopropanecarboxamide
   Show/Hide
C31H39N3O2
 1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CP0852199
3,3-difluoro-N-((1S)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutyl)cyclobutanecarboxamide
   Show/Hide
C26H38ClF2N5O
 1
1
IC50 = 1.3 nM
   TI
   LI
   LO
   TS
CP0904500
4,4-difluoro-N-((1S)-3-(3-(5-isopropyl-3-methyl-1H-1,2,4-triazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl)-1-phenylpropyl)cyclohexanecarboxamide
   Show/Hide
C29H41F2N5O
 1
1
IC50 = 1.4 nM
   TI
   LI
   LO
   TS
CP0515639
N-[(1S)-3-[4-[[2-(3-chlorophenyl)acetyl]-ethylamino]piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C30H40ClN3O2
 1
1
IC50 = 1.54 nM
   TI
   LI
   LO
   TS
CP0503482
N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C26H39N5O
 1
1
IC50 = 2 nM
   TI
   LI
   LO
   TS
CP0427113
N-[(1S)-3-[4-[[2-(2,4-dichlorophenyl)acetyl]-ethylamino]piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C30H39Cl2N3O2
 1
1
IC50 = 2.33 nM
   TI
   LI
   LO
   TS
CP0428176
N-benzyl-N-[1-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]piperidin-4-yl]cyclobutanecarboxamide
   Show/Hide
C31H41N3O2
 1
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
CP0452628
(+/-)-N-((1S)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutyl)isobutyramide
   Show/Hide
C25H39N5O
 1
1
IC50 = 3.11 nM
   TI
   LI
   LO
   TS
CP0514700
benzyl N-[1-[(4S)-4-(cyclobutanecarbonylamino)-4-phenylbutan-2-yl]piperidin-4-yl]-N-ethylcarbamate
   Show/Hide
C30H41N3O3
 1
1
IC50 = 3.16 nM
   TI
   LI
   LO
   TS
CP0493396
(+/-)-2-cyclopropyl-N-((1S)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutyl)acetamide
   Show/Hide
C26H39N5O
 1
1
IC50 = 3.16 nM
   TI
   LI
   LO
   TS
CP0514701
4-chlorophenyl 1-((4S)-4-(cyclobutanecarboxamido)-4-phenylbutan-2-yl)piperidin-4-yl(ethyl)carbamate
   Show/Hide
C29H38ClN3O3
 1
1
IC50 = 3.4 nM
   TI
   LI
   LO
   TS
CP0504016
4-fluorophenyl 1-((4S)-4-(cyclobutanecarboxamido)-4-phenylbutan-2-yl)piperidin-4-yl(ethyl)carbamate
   Show/Hide
C29H38FN3O3
 1
1
IC50 = 3.63 nM
   TI
   LI
   LO
   TS
CP0419115
N-[(1S)-3-[4-[ethyl-[2-(4-methylphenyl)acetyl]amino]piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C31H43N3O2
 1
1
IC50 = 3.76 nM
   TI
   LI
   LO
   TS
CP0554450
(+/-)-N-((1S)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutyl)cyclopropanecarboxamide
   Show/Hide
C25H37N5O
 1
1
IC50 = 3.93 nM
   TI
   LI
   LO
   TS
CP0431532
N-[1-[(4S)-4-(cyclobutanecarbonylamino)-4-phenylbutan-2-yl]piperidin-4-yl]-N-ethyl-4-fluorobenzamide
   Show/Hide
C29H38FN3O2
 1
1
IC50 = 4.83 nM
   TI
   LI
   LO
   TS
CP0565562
(+/-)-1-Oxo-hexahydro-1lambda*4*-thiopyran-4-carboxylic acid{(S)-3-[4-(3-isopropyl-5-methyl-[1,2,4]triazol-4-yl)-piperidin-1-yl]-1-phenyl-butyl}-amide
   Show/Hide
C27H41N5O2S
 1
1
IC50 = 4.87 nM
   TI
   LI
   LO
   TS
CP0418943
N-[(1S)-3-[4-[ethyl-[2-(4-methoxyphenyl)acetyl]amino]piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C31H43N3O3
 1
1
IC50 = 5 nM
   TI
   LI
   LO
   TS
CP0511449
(+/-)-1,1-Dioxo-hexahydro-1lambda*6*-thiopyran-4-carboxylic acid{(S)-3-[4-(3-isopropyl-5-methyl-[1,2,4]triazol-4-yl)-piperidin-1-yl]-1-phenyl-butyl}-amide
   Show/Hide
C27H41N5O3S
 1
1
IC50 = 6.12 nM
   TI
   LI
   LO
   TS
CP0514370
(S)-4,4-difluoro-N-(3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylpropyl)cyclohexanecarboxamide
   Show/Hide
C27H39F2N5O
 1
1
IC50 = 7.5 nM
   TI
   LI
   LO
   TS
CP0423244
N-[(1S)-3-[4-[ethyl-(2-phenylacetyl)amino]piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C30H41N3O2
 1
1
IC50 = 13.4 nM
   TI
   LI
   LO
   TS
CP0503485
N-[(1S)-3-[(1R,5S)-3-[ethyl-[2-(4-methoxyphenyl)acetyl]amino]-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclobutanecarboxamide
   Show/Hide
C32H43N3O3
 1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0431533
N-[(1S)-3-[4-[ethyl-[2-(2-methoxyphenyl)acetyl]amino]piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C31H43N3O3
 1
1
IC50 = 17.9 nM
   TI
   LI
   LO
   TS
CP0419118
N-[(1S)-3-[4-(3-methyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C23H32N4O2
 1
1
IC50 = 21.4 nM
   TI
   LI
   LO
   TS
CP0423206
(4-((1-benzhydrylazetidin-3-yl)(methyl)amino)piperidin-1-yl)(2,4-dimethylpyridin-3-yl)methanone
   Show/Hide
C30H36N4O
 1
1
IC50 = 24 nM
   TI
   LI
   LO
   TS
CP0510218
4-chloro-N-(1-((4S)-4-(cyclobutanecarboxamido)-4-phenylbutan-2-yl)piperidin-4-yl)-N-ethylbenzamide
   Show/Hide
C29H38ClN3O2
 1
1
IC50 = 25.3 nM
   TI
   LI
   LO
   TS
CP0554451
(+/-)-1-acetyl-N-((1S)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutyl)piperidine-4-carboxamide
   Show/Hide
C29H44N6O2
 1
1
IC50 = 28.7 nM
   TI
   LI
   LO
   TS
CP0506600
3,4-dichloro-N-(1-((4S)-4-(cyclobutanecarboxamido)-4-phenylbutan-2-yl)piperidin-4-yl)-N-ethylbenzamide
   Show/Hide
C29H37Cl2N3O2
 1
1
IC50 = 33.7 nM
   TI
   LI
   LO
   TS
CP0478982
N-[(1S)-3-[4-(3,5-dimethyl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C24H35N5O
 1
1
IC50 = 37.5 nM
   TI
   LI
   LO
   TS
CP0522542
(4-(3-benzhydryl-3,8-diazabicyclo[3.2.1]octan-8-yl)piperidin-1-yl)(2,4-dimethylpyridin-3-yl)methanone
   Show/Hide
C32H38N4O
 1
1
IC50 = 41 nM
   TI
   LI
   LO
   TS
CP0423246
(S)-N-(3-(4-(2-(4-methoxyphenyl)acetamido)piperidin-1-yl)-1-phenylpropyl)cyclobutanecarboxamide
   Show/Hide
C28H37N3O3
 1
1
IC50 = 48 nM
   TI
   LI
   LO
   TS
CP0555029
4,4-difluoro-N-((1S,3S)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutyl)cyclohexanecarboxamide
   Show/Hide
C28H41F2N5O
 1
1
IC50 = 49.9 nM
   TI
   LI
   LO
   TS
CP0388630
(+/-)-N-((1S)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutyl)-2-(2,2,2-trifluoroethoxy)acetamide
   Show/Hide
C25H36F3N5O2
 1
1
IC50 = 52.8 nM
   TI
   LI
   LO
   TS
CP0506027
N-[2-[3-(2,2-diphenylethyl)piperidin-1-yl]ethyl]-2,4-dimethylpyridine-3-carboxamide
   Show/Hide
C29H35N3O
 1
1
IC50 = 56 nM
   TI
   LI
   LO
   TS
CP0904501
4,4-difluoro-N-((1S)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutyl)cyclohexanecarboxamide
   Show/Hide
C28H42ClF2N5O
 1
1
IC50 = 62 nM
   TI
   LI
   LO
   TS
CP0503483
N-[1-[(4S)-4-(cyclobutanecarbonylamino)-4-phenylbutan-2-yl]piperidin-4-yl]-N-ethyl-4-methoxybenzamide
   Show/Hide
C30H41N3O3
 1
1
IC50 = 64.4 nM
   TI
   LI
   LO
   TS
CP0503484
N-[1-[(4S)-4-(cyclobutanecarbonylamino)-4-phenylbutan-2-yl]piperidin-4-yl]-N-ethylbenzamide
   Show/Hide
C29H39N3O2
 1
1
IC50 = 73.5 nM
   TI
   LI
   LO
   TS
CP0388632
(+/-)-3,3,3-trifluoro-N-((1S)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutyl)propanamide
   Show/Hide
C24H34F3N5O
 1
1
IC50 = 85.3 nM
   TI
   LI
   LO
   TS
CP0474798
(+/-)-N-((1S)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutyl)acetamide
   Show/Hide
C23H35N5O
 1
1
IC50 = 89.2 nM
   TI
   LI
   LO
   TS
CP0504017
N-[(1S)-1-phenyl-3-[4-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]butyl]cyclobutanecarboxamide
   Show/Hide
C25H36N4O2
 1
1
IC50 = 94.6 nM
   TI
   LI
   LO
   TS
CP0506026
(3-((1-benzhydrylpiperidin-4-yl)(methyl)amino)azetidin-1-yl)(2,4-dimethylpyridin-3-yl)methanone
   Show/Hide
C30H36N4O
 1
1
IC50 = 102 nM
   TI
   LI
   LO
   TS
CP0373500
N-[[4-benzyl-1-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]piperidin-4-yl]methyl]cyclopropanecarboxamide
   Show/Hide
C31H41N3O2
 1
1
IC50 = 145 nM
   TI
   LI
   LO
   TS
CP0474799
(+/-)-N-((1S)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutyl)tetrahydro-2H-pyran-4-carboxamide
   Show/Hide
C27H41N5O2
 1
1
IC50 = 164 nM
   TI
   LI
   LO
   TS
CP0457693
(+/-)-N-((1S)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutyl)morpholine-4-carboxamide
   Show/Hide
C26H40N6O2
 1
1
IC50 = 176 nM
   TI
   LI
   LO
   TS
CP0474800
(+/-)-N-((1S)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutyl)-4-methylpiperazine-1-carboxamide
   Show/Hide
C27H43N7O
 1
1
IC50 = 187 nM
   TI
   LI
   LO
   TS
CP0509412
(4-(8-benzhydryl-3,8-diazabicyclo[3.2.1]octan-3-yl)piperidin-1-yl)(2,4-dimethylpyridin-3-yl)methanone
   Show/Hide
C32H38N4O
 1
1
IC50 = 313 nM
   TI
   LI
   LO
   TS
CP0493397
(+/-)-methyl(1S)-3-(4-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl)-1-phenylbutylcarbamate
   Show/Hide
C23H35N5O2
 1
1
IC50 = 315 nM
   TI
   LI
   LO
   TS
CP0419116
N-[(1S)-1-phenyl-3-[4-(4-pyridin-4-yl-1H-pyrazol-5-yl)piperidin-1-yl]butyl]cyclobutanecarboxamide
   Show/Hide
C28H35N5O
 1
1
IC50 = 382 nM
   TI
   LI
   LO
   TS
CP0503486
N-[(1S)-3-[4-[5-[(dimethylamino)methyl]-1,3,4-oxadiazol-2-yl]piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C25H37N5O2
 1
1
IC50 = 540 nM
   TI
   LI
   LO
   TS
CP0373501
(S)-N-benzyl-N-(1-(1-(2,6-dimethylbenzoyl)piperidin-4-yl)pyrrolidin-3-yl)cyclopropanecarboxamide
   Show/Hide
C29H37N3O2
 1
1
IC50 = 1230 nM
   TI
   LI
   LO
   TS
CP0478983
N-[(1S)-3-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C23H32N4O2
 1
1
IC50 = 1849 nM
   TI
   LI
   LO
   TS
CP0423245
N-[(1S)-3-[4-(2-oxo-5-phenyl-1H-imidazol-3-yl)piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C29H36N4O2
 1
1
IC50 = 2310 nM
   TI
   LI
   LO
   TS
CP0504296
N-[[1-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]azetidin-3-yl]-phenylmethyl]acetamide
   Show/Hide
C26H33N3O2
 1
1
IC50 = 2490 nM
   TI
   LI
   LO
   TS
CP0423207
N-benzyl-N-[1-[1-(2,6-dimethylbenzoyl)piperidin-4-yl]azetidin-3-yl]cyclopropanecarboxamide
   Show/Hide
C28H35N3O2
 1
1
IC50 = 5800 nM
   TI
   LI
   LO
   TS
CP0503487
N-[(1S)-3-[4-[ethyl-[methyl(phenyl)carbamoyl]amino]piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C30H42N4O2
 1
1
IC50 = 6430 nM
   TI
   LI
   LO
   TS
CP0419117
N-[(1S)-3-[4-[ethyl-(2-methyl-2-phenylpropanoyl)amino]piperidin-1-yl]-1-phenylbutyl]cyclobutanecarboxamide
   Show/Hide
C32H45N3O2
 1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Uterus)
Cell Line Name Organism Disease
C-33 A Homo sapiens (Human) Human papillomavirus-independent cervical squamous cell carcinoma
HeLa Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
H1HeLa Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
L-02 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HeLa S3 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
KB Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
SGC-7901 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HeLa Kyoto Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HL2/3 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
KB-V1 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HeLa-MAGI Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
BEL-7402/5-FU Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
BGC-823 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
KB-ChR-8-5 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HeLa-MAGI-CCR5 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
P4 MAGI CCR5+ Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
KB-3-1 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
TZM-bl Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
KB-ChR-8-5-11 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
NCTC 2544 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HEp-2 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
SMMC-7721 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HG5LN Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
Chang Liver Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
Girardi Heart Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
MDR-KB-VCR Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
MDR-KB-VIN Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HeLa R1-11 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HeLa-T5 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HeLa/STAT3-luc Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HLR-CREB Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HeLa-A2A Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
HeLa-A3 Homo sapiens (Human) Human papillomavirus-related cervical adenocarcinoma
C-4-I Homo sapiens (Human) Human papillomavirus-related cervical squamous cell carcinoma
SiHa Homo sapiens (Human) Human papillomavirus-related cervical squamous cell carcinoma
SK-E2 Homo sapiens (Human) Uterine corpus leiomyosarcoma
MES-SA/Dx5 Homo sapiens (Human) Uterine corpus sarcoma
MES-SA Homo sapiens (Human) Uterine corpus sarcoma